Head Office Novartis International AG CH-4002 Basel Switzerland
+41 61 324 11 11 +41 61 324 80 01 Monday - Friday, 8:30 - 17:00, GMT+1 (Central European Time)
More information
Novartis International AG Investor Relations P.O. Box CH-4002 Basel Switzerland
+41 61 324 79 44 investor.relations@novartis.com
Global Media Relations Eric Althoff Basel, Switzerland
+41 61 324 7999 eric.althoff@novartis.com
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
Reporting side effects
We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.»
Novartis has a diverse healthcare portfolio, including innovative pharmaceuticals, eye care products, generics, consumer health products, and vaccines and diagnostic tools. »
We strive to provide our associates with the safest possible workplace and to promote their health and well-being. We are an integral part of the communities that host our operations. We pay living wages worldwide, contributing to the stability and prosperity of these communities. »
View all stories
At Novartis, we often achieve success through close collaboration with partners who share a common vision and complementary strengths. »
We operate in 140 countries, with our global headquarters in Basel, Switzerland. »
Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz. »
Rankings and awards
Fact sheet
Associate videos
Corporate organizational structure (23 KB)
Novartis campus brochure (486 KB)
Connecting with patients brochure (512 KB)
Annual report 2012 >